It has been shown that N-methylpurine DNA glycosylase (MPG) and Polβ expression predict the sensitivity to the alkylating cancer drug temozolomide [30] and that Polβ-dependent 5’dRP lyase activity is the rate-limiting step in BER in breast cancer cells. Here, POLB is linked to breast carcinoma.